Substituted estratriene derivatives as 17BETA HSD inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 16, 2012
Grant Date -
Oct 16, 2008
app pub date -
Nov 29, 2007
filing date -
Nov 30, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Substituted estratriene compounds of formula (I) useful in therapy, especially in the treatment or inhibition of a steroid hormone dependent disorder requiring the inhibition of a 17β-hydroxysteroid dehydrogenase (17β-HSD) type 1, type 2 and/or type 3 enzyme, as well as their salts, pharmaceutical compositions containing such compounds and processes for preparing such compounds.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully